This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Insulin Resistance
and you are
between 18 and 60
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The investigators will test the null hypothesis that there will be no changes in the insulin-mediated suppression of endogenous glucose production (EGP) in response to autonomic blockade. To test this hypothesis, the investigators propose to determine the role of the autonomic nervous system in hepatic insulin resistance.

Provided treatments

  • Drug: Trimethaphan
  • Other: Saline
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028571. The sponsor of the trial is Vanderbilt University Medical Center and it is looking for 12 volunteers for the current phase.
Official trial title:
Acute Sympathetic Blockade and Endogenous Glucose Production